Radioiodine (I-131) therapy provides the most durable resolution of feline hyperthyroidism with excellent long-term welfare outcomes compared to medication or surgery.
Radioiodine offers the most welfare-positive long-term resolution of feline hyperthyroidism. The temporary isolation required (10-14 days post-treatment) is the primary welfare cost - some cats find this stressful. But the alternative of lifelong daily medication involves daily handling stress, owner compliance challenges, and the ongoing risk of inadequate control. Surgical thyroidectomy in typically elderly hyperthyroid cats carries meaningful anesthetic risk. Radioiodine's single-treatment cure rate, normal life expectancy post-treatment, and freedom from ongoing medication burden make it the welfare-optimal choice for cats where facilities are accessible.